AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that has grown its revenues at an average annual rate of 20% over the past decade. AFT raised an estimated NZ$33m in its December 2015 public offering, which it will use to accelerate new product development and move into new geographies including the EU and US. The company trades at a still relatively modest 4.2x EV/sales based on TTM revenues to September 2015.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Investing to accelerate long-term growth
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that has grown its revenues at an average annual rate of 20% over the past decade. AFT raised an estimated NZ$33m in its December 2015 public offering, which it will use to accelerate new product development and move into new geographies including the EU and US. The company trades at a still relatively modest 4.2x EV/sales based on TTM revenues to September 2015.